AnalystsAndy Chen
Andy Chen's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 18%
#891 out of 4980 analysts
Average Return
+37.8%
Win Rate
56%10 out of 18
Risk vs Reward
Poor
Good

Andy Chen's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Alpine Immune Sciences IncALPN
+546.47%$10.05$64.97
2023-10-17 -
2024-05-17
Strong Buy
Insmed IncINSM
+175.86%$28.75$79.31
2024-02-14 -
2025-02-14
Buy
Zenas Biopharma IncZBIO
+118.80%$7.66$16.76
2025-02-03 -
2025-08-14
Buy
Avidity Biosciences IncRNA
+56.91%$29.36$46.07
2025-06-16 -
2025-08-14
Buy
Moonlake ImmunotherapeuticsMLTX
+40.00%$39.20$54.88
2025-05-18 -
2025-08-14
Buy

Andy Chen Analyst Color

Get additional color on Andy Chen's coverage of popular stocks

Andy Chen's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Verona Pharma PLCVRNA
1Buy$170.00+61.49%Initiates Coverage On
a month ago
Bridgebio Pharma IncBBIO
1Buy$49.00-4.26%Initiates Coverage On
2 months ago
Avidity Biosciences IncRNA
1Buy$55.00+19.38%Initiates Coverage On
2 months ago
Moonlake ImmunotherapeuticsMLTX
1Buy$61.00+11.15%Upgrades
3 months ago
Intellia Therapeutics IncNTLA
1Buy$21.00+92.66%Upgrades
4 months ago
Oruka Therapeutics IncORKA
1Buy$20.00+33.33%Initiates Coverage On
6 months ago
Vera Therapeutics IncVERA
1Buy$49.00+130.37%Initiates Coverage On
6 months ago
Zenas Biopharma IncZBIO
1Buy$19.00+13.37%Initiates Coverage On
6 months ago
Argenx SeARGX
1Buy$697.00+6.83%Upgrades
9 months ago
Celldex Therapeutics IncCLDX
1Buy$51.00+104.49%Reiterates
a year ago
Kymera Therapeutics IncKYMR
1Buy$65.00+56.44%Upgrades
a year ago
Roivant Sciences LtdROIV
1Buy$17.00N/AInitiates Coverage On
2 years ago
Immunovant IncIMVT
1Buy$55.00N/AInitiates Coverage On
2 years ago
Insmed IncINSM
1Buy$42.00N/AInitiates Coverage On
2 years ago
Rapt Therapeutics IncRAPT
2Buy$312.00N/AInitiates Coverage On
2 years ago
Alpine Immune Sciences IncALPN
1Strong Buy$18.00N/AInitiates Coverage On
2 years ago
Affimed NvAFMDQ
1Strong Buy$60.00N/AAssumes
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.